Assessment of Schistosoma mansoni induced intestinal inflammation by means of eosinophil cationic protein, eosinophil protein X and myeloperoxidase before and after treatment with praziquantel

Acta Tropica

Volumn 105, Issue 3, 2008, Pages 253-259

  Reimert, Claus M ^a   Tukahebwa, Edridah M ^b   Kabatereine, Narcis B ^b   Dunne, David W ^c   Vennervald, Birgitte J ^a  

^a DANISH BILHARZIASIS LABORATORY   (Denmark)

^b MINISTRY OF HEALTH   (Uganda)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Eosinophil cationic protein; Eosinophil protein X; Intestinal inflammation; Morbidity; Myeloperoxidase; Schistosoma mansoni

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL PROTEIN X; MYELOPEROXIDASE; PRAZIQUANTEL;

ASSESSMENT METHOD; CONCENTRATION (COMPOSITION); DIGESTIVE SYSTEM DISORDER; DISEASE TREATMENT; DRUG; ENZYME ACTIVITY; FECES; FISHING COMMUNITY; FLATWORM; MEASUREMENT METHOD; PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; ENTERITIS; FECES ANALYSIS; FECES LEVEL; FEMALE; HUMAN; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; REINFECTION; REPEATED DRUG DOSE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; UGANDA;

ADOLESCENT; ADULT; ANIMALS; ANTHELMINTICS; BIOLOGICAL MARKERS; CHILD; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL-DERIVED NEUROTOXIN; FECES; HUMANS; INTESTINES; MIDDLE AGED; PARASITE EGG COUNT; PEROXIDASE; PRAZIQUANTEL; PREVALENCE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; UGANDA;

AFRICA; BUGOIGO; EAST AFRICA; EAST AFRICAN LAKES; LAKE ALBERT; SUB-SAHARAN AFRICA; UGANDA; WESTERN PROVINCE [UGANDA];

SCHISTOSOMA MANSONI;

EID: 39149144296     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2007.11.004     Document Type: Article

References (52)

1. Berstad A., Borkje B., Riedel B., Elsayed S., and Berstad A. Increased fecal eosinophil cationic protein in inflammatory bowel disease. Hepatogastroenterology 40 (1993) 276-278
2. Bischoff S.C., Grabowsky J., and Manns M.P. Quantification of inflammatory mediators in stool samples of patients with inflammatory bowel disorders and controls. Dig. Dis. Sci. 42 (1997) 394-403
3. Booth M., Vennervald B.J., Kenty L., Butterworth A.E., Kariuki H.C., Kadzo H., Ireri E., Amaganga C., Kimani G., Mwatha J.K., Otedo A., Ouma J.H., Muchiri E., and Dunne D.W. Micro-geographical variation in exposure to Schistosoma mansoni and malaria, and exacerbation of splenomegaly in Kenyan school-aged children. BMC Infect. Dis. 4 (2004) 13
4. Booth M., Vennervald B.J., Kabatereine N.B., Kazibwe F., Ouma J.H., Kariuki C.H., Muchiri E., Kadzo H., Ireri E., Kimani G., Mwatha J.K., and Dunne D.W. Hepatosplenic morbidity in two neighbouring communities in Uganda with high levels of Schistosoma mansoni infection but very different durations of residence. Trans. R. Soc. Trop. Med. Hyg. 98 (2004) 125-136
5. Carlson M., Raab Y., Peterson C., Hallgren R., and Venge P. Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion. Am. J. Gastroenterol. 94 (1999) 1876-1883
6. Carlson M., Raab Y., Seveus L., Xu S., Hallgren R., and Venge P. Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis. Gut 50 (2002) 501-506
7. Cheever A.W. A quantitative post-mortem study of Schistosomiasis mansoni in man. Am. J. Trop. Med. Hyg. 17 (1968) 38-64
8. Cheever A.W., Kamel I.A., Elwi A.M., Mosimann J.E., and Danner R. Schistosoma mansoni and S. haematobium infections in Egypt. II. Quantitative parasitological findings at necropsy. Am. J. Trop. Med. Hyg. 26 (1977) 702-716
9. Cheever A.W., Kamel I.A., Elwi A.M., Mosimann J.E., Danner R., and Sippel J.E. Schistosoma mansoni and S. haematobium infections in Egypt. III. Extrahepatic pathology. Am. J. Trop. Med. Hyg. 27 (1978) 55-75
10. Chen M.-G., and Mott K.E. Progress in assessment of morbidity due to Schistosoma mansoni infection. Trop. Dis. Bull. 85 (1988) R1-R56
11. Chitsulo L., Engels D., Montresor A., and Savioli L. The global status of schistosomiasis and its control. Acta Trop. 77 (2000) 41-51
12. Dessein A.J., Marquet S., Henri S., El Wali N.E., Hillaire D., Rodrigues V., Prata A., Ali Q.M., Gharib B., de Reggi M., Magzoub M.M., Saeed O.K., Abdelhameed A.A., and Abel L. Infection and disease in human Schistosomiasis mansoni are under distinct major gene control. Microb. Infect. 1 (1999) 561-567
13. Doenhoff M.J., Modha J., Lambertucci J.R., and McLaren D.J. The immune dependence of chemotherapy. Parasitol. Today 7 (1991) 16-18
14. Dunne D.W., Butterworth A.E., Fulford A.J.C., Kariuki H.C., Langley J.G., Ouma J.H., Capron A., Pierce R.J., and Sturrock R.F. Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur. J. Immunol. 22 (1992) 1483-1494
15. Fredens K., Dybdahl H., Dahl R., and Baandrup U. Extra cellular deposit of the cationic proteins ECP and EPX in tissue infiltrations of eosinophils related to tissue damage. APMIS 96 (1988) 711-719
16. Geboes K., El-Dosoky I., El-Wahab A., and Abou Almagd K. The immunopathology of Schistosoma mansoni granulomas in human colonic schistosomiasis. Virchows Arch. A: Pathol. Anat. Histopathol. 416 (1990) 527-534
17. Geboes K., El-Deeb G., El-Haddad S., Amer G., and El-Zayadi A.R. Vascular alterations of the colonic mucosa in schistosomiasis and portal colopathy. Hepatogastroenterology 42 (1995) 343-347
18. Gryseels B., Polman K., Clerinx J., and Kestens L. Human schistosomiasis. Lancet 368 (2006) 1106-1118
19. Hagan P., Wilkins H.A., Blumenthal U.J., Hayes R.J., and Greenwood B.M. Eosinophilia and resistance to Schistosoma haematobium in man. Parasite Immunol. 7 (1985) 625-632
20. Hagan P., Blumenthal U.J., Chaudri M., Greenwood B.M., Hayes R.J., Hodgson J., Kelly M., Knight C., Simpson A.J.G., Smithers S.R., and Wilkins H.A. Resistance to reinfection with Schistosoma haematobium in Gambian children: analysis of their immune responses. Trans. R. Soc. Trop. Med. Hyg. 81 (1987) 938-946
21. Hagan P., Blumenthal U.J., Dunn D., Simpson A.J., and Wilkins H.A. Human IgE IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 349 (1991) 243-245
22. Hallgren R., Colombel J.F., Dahl R., Fredens K., Kruse A., Jacobsen N.O., Venge P., and Rambaud J.C. Neutrophil and eosinophil involvement of the small bowel in patients with celiac disease and Crohn's disease: studies on the secretion rate and immunohistochemical localization of granulocyte granule constituents. Am. J. Med. 86 (1989) 56-64
23. Harris J.C., Dupont H.L., and Hornick R.B. Fecal leukocytes in diarrheal illness. Ann. Intern. Med. 76 (1972) 697-703
24. Hogan S.P., and Rothenberg M.E. Review article: the eosinophil as a therapeutic target in gastrointestinal disease. Aliment Pharmacol. Ther. 20 (2004) 1231-1240
25. Kato M., Kephart G.M., Talley N.J., Wagner J.M., Sarr M.G., Bonno M., McGovern T.W., and Gleich G.J. Eosinophil infiltration and degranulation in normal human tissue. Anat. Rec. 252 (1998) 418-425
26. Katz N.A., Chaves A., and Pellegrino J. A simple device for quantitative stool thick smear technique in Schistosomiasis mansoni. Rev. Inst. Med. Trop. São Paulo 14 (1972) 397-400
27. King C.H. Epidemiology of schistosomiasis: determinants of transmission of infection. In: Mahmoud A.A.F. (Ed). Schistosomiasis (2001), Imperial College Press, London, UK 115-132
28. Kouriba B., Traore H.A., Dabo A., Sangare L., Guindo H., Keita A.S., Reimert C.M., van Dam G.J., Deelder A.M., Doumbo O., and Dessein A.J. Urinary disease in 2 Dogon populations with different exposure to Schistosoma haematobium infection: progression of bladder and kidney diseases in children and adults. J. Infect. Dis. 192 (2005) 2152-2159
29. Kristjansson G., Venge P., Wanders A., Loof L., and Hallgren R. Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome. Gut 53 (2004) 1806-1812
30. Leutscher P.D., Reimert C.M., Vennervald B.J., Ravaoalimalala V.E., Ramarokoto C.E., Serieye J., Raobelison A., Rasendramino M., Christensen N.O., and Esterre P. Morbidity assessment in urinary schistosomiasis infection through ultrasonography and measurement of eosinophil cationic protein (ECP) in urine. Trop. Med. Int. Health 5 (2000) 88-93
31. Magnusson J., Gellerstedt M., Ahlstedt S., Andersson B., Bengtsson U., Telemo E., Hansson T., and Peterson C.G. A kinetic study in adults with food hypersensitivity assessed as eosinophil activation in fecal samples. Clin. Exp. Allergy 33 (2003) 1052-1059
32. Majamaa H., Laine S., and Miettinen A. Eosinophil protein X and eosinophil cationic protein as indicators of intestinal inflammation in infants with atopic eczema and food allergy. Clin. Exp. Allergy 29 (1999) 1502-1506
33. Malaquias L.C., Falcao P.L., Silveira A.M., Gazzinelli G., Prata A., Coffman R.L., Pizziolo V., Souza C.P., Colley D.G., and Correa-Oliveira R. Cytokine regulation of human immune response to Schistosoma mansoni: analysis of the role of IL-4 IL-5 and IL-10 on peripheral blood mononuclear cell responses. Scand. J. Immunol. 46 (1997) 393-398
34. Meeusen E.N., and Balic A. Do eosinophils have a role in the killing of helminth parasites?. Parasitol. Today 16 (2000) 95-101
35. Mohamed A.R., al Karawi M., and Yasawy M.I. Schistosomal colonic disease. Gut 31 (1990) 439-442
36. Moore D.L., Grove D.I., and Warren K.S. The Schistosoma mansoni egg granuloma: quantitation of cell populations. J. Pathol. 121 (1977) 41-50
37. Peterson C.G., Eklund E., Taha Y., Raab Y., and Carlson M. A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease. Am. J. Gastroenterol. 97 (2002) 1755-1762
38. Raab Y., Fredens K., Gerdin B., and Hallgren R. Eosinophil activation in ulcerative colitis: studies on mucosal release and localization of eosinophil granule constituents. Dig. Dis. Sci. 43 (1998) 1061-1070
39. Reimert C.M., Venge P., Kharazmi A., and Bendtzen K. Detection of eosinophil cationic protein (ECP) by an enzyme-linked immunosorbent assay. J. Immunol. Methods 138 (1991) 285-290
40. Reimert C.M., Minuva U., Kharazmi A., and Bendtzen K. Eosinophil protein X/eosinophil derived neurotoxin (EPX/EDN). Detection by enzyme-linked immunosorbent assay and purification from normal human urine. J. Immunol. Methods 141 (1991) 97-104
41. Reimert C.M., Ouma J.H., Mwanje M.T., Magak P., Poulsen L.K., Vennervald B.J., Christensen N.O., Kharazmi A., and Bendtzen K. Indirect assessment of eosinophiluria in urinary schistosomiasis using eosinophil cationic protein (ECP) and eosinophil protein X (EPX). Acta Trop. 54 (1993) 1-12
42. Reimert C.M., Mshinda H.M., Hatz C.F., Kombe Y., Nkulila T., Poulsen L.K., Christensen N.O., and Vennervald B.J. Quantitative assessment of eosinophiluria in Schistosoma haematobium infections: a new marker of infection and bladder morbidity. Am. J. Trop. Med. Hyg. 62 (2000) 19-28
43. Reimert C.M., Fitzsimmons C.M., Joseph S., Mwatha J.K., Jones F.M., Kimani G., Hoffmann K.F., Booth M., Kabatereine N.B., Dunne D.W., and Vennervald B.J. Eosinophil activity in Schistosoma mansoni infections in vivo and in vitro in relation to plasma cytokine profile pre- and post-treatment with praziquantel. Clin. Vaccine Immunol. 13 (2006) 584-593
44. Richter J., Hatz C.F., and Haussinger D. Ultrasound in tropical and parasitic diseases. Lancet 362 9387 (2003) 900-902
45. Rothenberg M.E. Eosinophilic gastrointestinal disorders (EGID). J. Allergy Clin. Immunol. 113 (2004) 11-28
46. Saitoh O., Kojima K., Sugi K., Matsuse R., Uchida K., Tabata K., Nakagawa K., Kayazawa M., Hirata I., and Katsu K. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease. Am. J. Gastroenterol. 94 (1999) 3513-3520
47. Strickland G.T. Gastrointestinal manifestations of schistosomiasis. Gut 35 (1994) 1334-1337
48. Sugi K., Saitoh O., Hirata I., and Katsu K. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins. Am. J. Gastroenterol. 91 (1996) 927-934
49. Utzinger J., Keiser J., Shuhua X., Tanner M., and Singer B.H. Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrob. Agents Chemother. 47 (2003) 1487-1495
50. Venge P., Dahl R., Fredens K., and Peterson C.G. Epithelial injury by human eosinophils. Am. Rev. Respir. Dis. 138 (1988) S54-S57
51. WHO, and Expert Committee on the Control of Schistosomiasis. Public health impact of schistosomiasis: disease and mortality. Bull. World Health Organ. 71 (1993) 657-662
52. Yamamoto-Furusho J.K., and Korzenik J.R. Crohn's disease: innate immunodeficiency?. World J Gastroenterol. 12 (2006) 6751-6755